You are here

Home > News & Stories > Blog

Blog

6 ‘made in Catalonia’ Covid-19 prediction and prognosis methods

11.05.2020

Predicting and establishing the prognosis of diseases is key to controlling them. Biocat will provide support for the 19 research projects in the BioRegion awarded €4 million from the Catalan Ministry of Health to research the pandemic, 6 of which are looking into possible prediction or...

3 Catalan Covid-19 vaccines

11.05.2020

A few days ago, the 19 research projects in the BioRegion awarded €4 million from the Catalan Ministry of Health to research the pandemic, with technical support from Biocat, were announced. Of these projects, 3 are researching potential vaccines for the SARS-CoV-2 virus. Let’s look at the...

5 existing drugs that could be used for Covid-19

08.05.2020

Five research projects in the BioRegion of Catalonia are investigating how to take advantage of therapies already in use for other diseases to treat Covid-19. They have received funding from the Catalan Ministry of Health to study this new path towards a possible cure to the pandemic. Let’s look...

Will Covid-19 affect investment in the biomedical sector?

28.04.2020

The BioRegion of Catalonia has a solid local investment fabric and the number of international investors has grown tenfold over the past 5 years. How will the pandemic affect their activity? Companies are seeing some operations postponed, but investors, for now, are optimistic: activity won’t...

Marta-Gaia Zanchi (Nina Capital): “This year we will see lower investment in health technology concentrated in fewer deals”

28.04.2020

Dr. Marta-Gaia Zanchi, founder and managing partner of Nina Capital, explains how the Covid-19 pandemic could affect investment in digital health and medical technology.

Clara Campàs (Asabys Partners): “Society’s growing interest in science due to Covid-19 could boost investment in healthcare”

27.04.2020

Clara Campàs, partner and co-founder of specialized venture capital fund Asabys Partners, analyzes how the global Covid-19 crisis is affecting the sector and is optimistic about the future of investment in healthcare.

Joël Jean-Mairet (Ysios Capital): “The Covid-19 crisis has to remind us of the need to innovate in the life sciences”

27.04.2020

Joël Jean-Mairet, managing partner of Ysios Capital, explained how he sees this crisis from the perspective of a venture capital fund and warns that continued investment in healthcare innovation is more necessary than ever.

Montserrat Vendrell (Alta Life Sciences): "Covid-19 is opening a lot of doors for business and investment opportunities in the healthcare sector”

27.04.2020

Montserrat Vendrell, partner in the Alta Life Sciences investment fund, explains how investors are experiencing the Covid-19 pandemic and highlights one of the few positives that may come out of this crisis: new opportunities in the healthcare sector.

Lluís Pareras (Invivo Ventures): “Stopping now would be a mistake”

27.04.2020

Lluís Pareras, founding partner of the new fund Invivo Ventures, is optimistic about the future of the life sciences sector and warns that companies need to keep working at a good pace these months so they don’t lose inertia.

5 Covid-19 therapies from Catalan research

23.04.2020

Biocat will provide support for the 19 research projects in the BioRegion awarded €4 million from the Catalan Ministry of Health to research the pandemic. 5 of these projects are researching new therapies using very diverse strategies. Let’s look at what they’re working on.

Developed by Drauta